Master in Biomedical Sciences, Professional focus in Preclinical Research
-
Schedule
regular course
- ECTS Credits 120
-
<unknown>
Code Name Staff Th.+Ex. Credits/Block 1 2 3 MSBMM110 Innovation in Biomedical Engineering Nolens Grégory 12h th. + 5h ex. 2 MSBMM107 Biotechnology : Principles and Scale-up Gillet Jean-Pierre 20h th. + 30h ex. 5 MSBMM106 Biopharmaceuticals Masereel Bernard 12h th. 2 MSBMM105 Laboratory Research Training Gillet Jean-Pierre 8h th. + 32h ex. 4 MSBMM119 Current Topics in Molecular Cell Biology Boonen Marielle 12h th. 2 MSBMM207 Project Management : Development of Biomarkers Gillet Jean-Pierre 12h th. 2 MSBMM205 Vaccinology, Immunotherapy Meurice François 20h th. 2 MSBMM203 Biomarkers, Biobanks, Personalized Medicine Mullier François George Fabienne D'HONDT Lionel 25h th. 3 MSBMM115 Drug and Society MALONNE HUGUES 12h th. 2 -
<unknown>
The student chooses 6 credits in the following list.
Code Name Staff Th.+Ex. Credits/Block 1 2 3 SBIOM134 Protein Structure and Function Wouters Johan De Bolle Xavier 22h th. 2 SBIOM133 Glycobiology Vincent Stéphane 22h th. 2 SBIOM128 Hot Topics in Microbiomes, Diabetes and Cardiovascular Diseases Arnould Thierry 22h th. 2 SBIOM124 Host Pathogen Interactions Van der Henst Charles Gillet Nicolas 22h th. 2 SBIOM122 Cancer Michiels Carine 22h th. 2 SBIOM121 Organelle Dysfunction as the Basis of Diseases Arnould Thierry 22h th. 2 SBIOM120 Stem Cells and Differentiation Renard Patricia 22h th. 2 SFCMM101 <unknown> 40h th. 3 MSBMM118 Cell Models Boonen Marielle 12h th. 2 SBIOM125 Normal and pathological ageing Chainiaux Florence 22h th. 3
-
-
<unknown>
Code Name Staff Th.+Ex. Credits/Block 1 2 3 MSBMM114 Introduction to Scientific Research 10 MSBMM113 Bioethics Ravez Laurent 20h th. 2 MSBMM108 Quality Assurance : GMP, GCP, GLP and Auditing Lienard Patricia 24h th. 3 MSBMM104 Statistics Applied to Preclinical and Clinical Studies Le Tallec David 20h th. + 20h ex. 4 MSBMM103 Clinical Trials Geysels Yves 24h th. + 30h ex. 6 MSBMM102 Preclinical Drug Development Gillet Jean-Pierre 24h th. + 30h ex. 6 MSBMM101 Pharmacotherapy MALONNE HUGUES 36h th. 4 MSBMM109_P28995 <unknown> MALONNE HUGUES 12h th. 2 MSBMM209 Professional Internship 20 MSBMM208 Master Thesis 23 MSBMM217 Pharmaco-Economy and Health Technology Assessment ETHGEN OLIVIER 20h th. 2 MSBMM216 Pharmacovigilance Dogne Jean-Michel 20h th. 2 -
<unknown>
The student chooses 6 credits in the following list.
Code Name Staff Th.+Ex. Credits/Block 1 2 3 MSBMM212 Introduction to Patient-Reported Outcomes DELBECQUE Laure 12h th. 2 MSBMM210 Perfectionnement d'anglais (niveau B2+) 30h th. 3 MSBMM220 Interdisciplinary Program in Healthcare Innovation 20h th. 4 SELVM202_P29108 <unknown> 30h th. 3 MSBMM221 Lecture series in dermato-cosmetic sciences 12h th. 2 MSBMM222 Biomarkers and surrogate markers in clinical dermatology trials Libon Florence 12h th. 2 SVETM209 <unknown> Muylkens Benoît 15h th. 2 SVETM202 Animal Pathology Kirschvink Nathalie 15h th. 2 SSPSM203 Philosophy of Life Sciences Leyens Stéphane 12h th. 3 SBIOM208 <unknown> Feron Olivier 15h th. 2 SFCMM201 <unknown> 40h th. 3 MSBMM214 Integrative Approach of Organelle Pathology Boonen Marielle 12h th. 3 MSBMM213 Investigator-Initiated Trials : Key Concepts and Best Practice Gauthier Marie-Pierre 12h th. 2
-
-
<unknown>
Code Name Staff Credits Hours/Quarter 1 2 MSBMM110 Innovation in Biomedical Engineering Nolens Grégory 2 12h th. + 5h ex. MSBMM107 Biotechnology : Principles and Scale-up Gillet Jean-Pierre 5 20h th. + 30h ex. MSBMM106 Biopharmaceuticals Masereel Bernard 2 12h th. MSBMM105 Laboratory Research Training Gillet Jean-Pierre 4 8h th. + 32h ex. MSBMM119 Current Topics in Molecular Cell Biology Boonen Marielle 2 12h th. MSBMM115 Drug and Society MALONNE HUGUES 2 12h th. -
<unknown>
The student chooses 6 credits in the following list.
Code Name Staff Credits Hours/Quarter 1 2 SBIOM134 Protein Structure and Function Wouters Johan De Bolle Xavier 2 22h th. SBIOM133 Glycobiology Vincent Stéphane 2 22h th. SBIOM128 Hot Topics in Microbiomes, Diabetes and Cardiovascular Diseases Arnould Thierry 2 22h th. SBIOM124 Host Pathogen Interactions Van der Henst Charles Gillet Nicolas 2 22h th. SBIOM122 Cancer Michiels Carine 2 22h th. SBIOM121 Organelle Dysfunction as the Basis of Diseases Arnould Thierry 2 22h th. SBIOM120 Stem Cells and Differentiation Renard Patricia 2 22h th. SFCMM101 <unknown> 3 40h th. MSBMM118 Cell Models Boonen Marielle 2 12h th. SBIOM125 Normal and pathological ageing Chainiaux Florence 3 22h th.
-
-
<unknown>
Code Name Staff Credits Hours/Quarter 1 2 MSBMM114 Introduction to Scientific Research 10 MSBMM113 Bioethics Ravez Laurent 2 20h th. MSBMM108 Quality Assurance : GMP, GCP, GLP and Auditing Lienard Patricia 3 24h th. MSBMM104 Statistics Applied to Preclinical and Clinical Studies Le Tallec David 4 20h th. + 20h ex. MSBMM103 Clinical Trials Geysels Yves 6 24h th. + 30h ex. MSBMM102 Preclinical Drug Development Gillet Jean-Pierre 6 24h th. + 30h ex. MSBMM101 Pharmacotherapy MALONNE HUGUES 4 36h th. MSBMM109_P28995 <unknown> MALONNE HUGUES 2 12h th.
-
<unknown>
Code Name Staff Credits Hours/Quarter 1 2 MSBMM207 Project Management : Development of Biomarkers Gillet Jean-Pierre 2 12h th. MSBMM205 Vaccinology, Immunotherapy Meurice François 2 20h th. MSBMM203 Biomarkers, Biobanks, Personalized Medicine Mullier François George Fabienne D'HONDT Lionel 3 25h th. -
<unknown>
Code Name Staff Credits Hours/Quarter 1 2 MSBMM209 Professional Internship 20 MSBMM208 Master Thesis 23 MSBMM217 Pharmaco-Economy and Health Technology Assessment ETHGEN OLIVIER 2 20h th. MSBMM216 Pharmacovigilance Dogne Jean-Michel 2 20h th. -
<unknown>
The student chooses 6 credits in the following list.
Code Name Staff Credits Hours/Quarter 1 2 MSBMM212 Introduction to Patient-Reported Outcomes DELBECQUE Laure 2 12h th. MSBMM210 Perfectionnement d'anglais (niveau B2+) 3 30h th. MSBMM220 Interdisciplinary Program in Healthcare Innovation 4 20h th. SELVM202_P29108 <unknown> 3 30h th. MSBMM221 Lecture series in dermato-cosmetic sciences 2 12h th. MSBMM222 Biomarkers and surrogate markers in clinical dermatology trials Libon Florence 2 12h th. SVETM209 <unknown> Muylkens Benoît 2 15h th. SVETM202 Animal Pathology Kirschvink Nathalie 2 15h th. SSPSM203 Philosophy of Life Sciences Leyens Stéphane 3 12h th. SBIOM208 <unknown> Feron Olivier 2 15h th. SFCMM201 <unknown> 3 40h th. MSBMM214 Integrative Approach of Organelle Pathology Boonen Marielle 3 12h th. MSBMM213 Investigator-Initiated Trials : Key Concepts and Best Practice Gauthier Marie-Pierre 2 12h th.
-
Admission requirements
Si vous avez un diplôme belge
ACCÈS DIRECT
- bachelier en sciences biomédicales ;
ACCÈS moyennant un éventuel COMPLÉMENT DE 15 CRÉDITS maximum
- bachelier en sciences pharmaceutiques, médecine, médecine vétérinaire, sciences biologiques, sciences dentaires, kinésithérapie et réadaptation, sciences de la motricité, sciences chimiques ;
- master en ingénieur civil en chimie et science des matériaux, sciences de la santé publique, kinésithérapie et réadaptation.
ACCÈS moyennant un COMPLÉMENT DE 15 À 30 CRÉDITS
- bachelier (type court) en sage-femme, infirmier responsable en soins généraux ;
- bachelier de spécialisation (type court) en anesthésie, soins intensifs et aide médicale urgente.
ACCÈS moyennant un COMPLÉMENT DE 30 À 60 CRÉDITS
- bachelier (type court) en diététique, ergothérapie, soins infirmiers, technologie en imagerie médicale, technologue de laboratoire médical ;
- bachelier (type court) en chimie orientation biochimie, biotechnologie, chimie appliquée, environnement;
- bachelier (promotion sociale) en soins infirmiers pour titulaires du brevet d'infirmier hospitalier.
ACCÈS SUR DOSSIER
- autre diplômé de l’enseignement supérieur de la Communauté française de Belgique ;
- diplômé de l’enseignement supérieur hors Communauté française de Belgique;
- sur base de VAE (Valorisation des acquis de l'expérience).
Pour les admissions en master, il y a lieu de prendre contact avec le service des inscriptions.
Si vous avez un diplôme non-belge
If you have a degree from an institution outside of Belgium, you will need to complete and return the admissions request form before 30 September (31 March for students from outside the European Union).
________________________________________________________________________________________________________________
Students with a first degree obtained in Belgium
> DIRECT ACCESS
- Bachelor in Biomedical Sciences.
> ACCESS subject to a maximum of 15 ADDITIONAL CREDITS
- Bachelor in Pharmacy, Medicine, Veterinary Medicine, Biology, Dentistry, Physiotherapy and Rehabilitation, Motor Sciences, Chemistry;
- Master in Chemical and Materials Science Engineering, Public Health, Physiotherapy and Rehabilitation.
> ACCESS subject to AN ADDITIONAL 15 TO 30 CREDITS
- Bachelor in Midwife, Nurse Responsible for General Care;
- Advanced Bachelor in Anaesthesia, Intensive Care and Emergency Medical Aid.
> ACCESS subject to AN ADDITIONAL 30 TO 60 CREDITS
- Bachelor in Dietetics, Occupational Therapy, Nursing, Medical Imaging Technologist, Medical Laboratory Technologist;
- Bachelor in Chemistry orientation Biochemistry, Biotechnology, Applied Chemistry, Environment;
- Bachelor in Nursing for holders of the certificate of Hospital Nurse.
> ACCESS BY APPLICATION
- other higher education qualifications obtained in the French Community of Belgium;
- higher education qualifications obtained outside of the French Community of Belgium;
- on the basis of VAE (‘Valorisation des acquis de l’expérience’ – recognition of previous experience)
For admission to Masters degrees, please contact the Admission Service.
Students with a first degree obtained outside of Belgium
If you have a degree from an institution outside of Belgium, you will need to complete and return the admissions request form before 30 September (31 March for students from outside the European Union): www.unamur.be/en/enrolment
Description
The 120-credit Master in Biomedical Sciences with professional focus in preclinical research centers the learning of the student on the laboratory phase of research that aims to identify the causes and consequences of diseases, putative drug targets, or products and techniques before they are tested on humans. It is based on a solid grounding in fundamental research, biopharmaceutics (pharmacotherapy, health technology assessment, biosynthetic drugs and pharmacovigilance), biotechnology and therapy (clinical and non-clinical experimental approaches, biomedical engineering).
The degree programme will boast a significant professional dimension thanks to visits to companies and hospitals, practical projects and a 5-month placement in a laboratory or company in Belgium or abroad.
The student will also have the opportunity to write a thesis based on their work in a research laboratory, working on a personal project right through from design to completion.
International mobility and openness
Students have the opportunity to spend part of their Master studying abroad, within the context of the Erasmus study programme.
Teaching methods
This Master comprises a few core lectures, complemented by courses selected by the students from a large list of topics. The emphasis is on interactive learning, via a series of practical and personal projects.
Students also have the opportunity to gain practical experience in handling animals, thanks to training which leads to professional certificates in laboratory animal sciences.
This programme has a particularly professional dimension, with several visits to companies and hospitals, practical projects and a 5-month placement in a laboratory or company, either in Belgium or abroad.
Aims and objectives
- To lead scientific projects which aim for greater understanding of the molecular and cellular mechanisms of pathologies and to improve treatment: to analyse raw data, interpret the results and present observations clearly - this includes basic and translational research projects;
- To master every stage of the development of new therapies, in particular biotechnology- or cell-related therapies;
- To develop biomarkers related to different therapies, for example using genetics and pharmacogenomics;
- To lead and monitor preclinical research development of new drugs and to be responsible for the administrative management of testing;
- To ensure the production quality of biotechnological and biosimilar products, cell therapies (stem cells), gene therapies, tissue engineering, medical devices (implants, drug delivery devices, etc.) and so on;
- To monitor the quality, safety and efficiency of a drug before it is placed on the market.
Assessment
- Year 1:
In January, students take exams based on the subjects studied during the first semester. In June, students take exams based on the subjects studied in the second semester.
For some subjects, there are regular evaluations based on reports submitted after each session of practical projects. Marks awarded for these practical projects represent a significant percentage of the final marks.
Students begin work on a thesis during the second semester and submit a report regarding progress made on this project in June.
- Year 2:
In January, students take exams based on the subjects studied during the first semester, and submit their completed thesis. The second semester is reserved for the placement, and a report on this placement is submitted in June.